AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Cancer Biology & Medicine Article
PDF (221.9 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Consensus

2017 Chinese expert consensus on the clinical application of serum marker for thyroid cancer

Ming Gao1, Minghua Ge2, Qinghai Ji3, Ruochuan Cheng4, Hankui Lu5, Haixia Guan6, Wei Cui7, Li Gao8, Zairong Gao9, Lin Guo10, Zhuming Guo11, Tao Huang12, Xiaoming Huang13, Yansong Lin14, Qinjiang Liu15, Xin Ni16, Jianwu Qin17, Li Ren18, Zhongyan Shan6, Hui Sun19, Xudong Wang1, Zhengang Xu20, Yang Yu1, Bin Zhang21, Daiwei Zhao22, Ying Zheng23, Jingqiang Zhu24, Xiangqian Zheng1 ( ),  Chinese Association of Thyroid Oncology (CATO), China Anti-Cancer Association
Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Department of Head and Neck, Zhejiang Cancer Hospital, Hangzhou 310022, China
Department of Head and Neck Tumor, Fudan University Shanghai Cancer Center, Shanghai 200433, China
Department of General Surgery, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China
Department of Nuclear Medicine, The Sixth Affiliated Hospital of Shanghai Jiao Tong University, Shanghai 200025, China
Department of Endocrinology, The First Hospital of China Medical University, Shenyang 110001, China
Department of Clinical Laboratory, Cancer Hospital Chinese Academy of Medical Science, Beijing 100021, China
Department of Head and Neck, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310020, China
Department of Nuclear Medicine, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan 430030, China
Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai 200433, China
Sun Yat-sen University Cancer Center, Guangzhou 510060, China
Department of Thyroid and Breast, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan 430030, China
Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing 100730, China
Department of Head and Neck, Gansu Provincial Cancer Hospital, Lanzhou 730050, China
Department of Head and Neck, Beijing Children’s Hospital, Capital Medical University, Beijing 100045, China
Department of Thyroid, Head and Neck, Henan Cancer Hospital, Zhengzhou 450008, China
Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Department of Thyroid, Sino Japanese Union Hospital of Jilin University, Changchun 130033, China
Department of Head and Neck, Cancer Hospital Chinese Academy of Medical Sciences, Beijing 100021, China
Department of Head and Neck, Peking Union Medical College Hospital, Beijing 100730, China
Department of General Surgery, The Second Affiliated Hospital of Guizhou Medical University, Kaili 556099, China
Department of Head and Neck, Jilin Tumor Hospital, Changchun 130012, China
Department of Thyroid and Breast, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610047, China
Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Cancer Biology & Medicine
Volume 15 Issue 4,
November 2018
Pages 468-477
DOI: 10.20892/j.issn.2095-3941.2018.0084

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Gao M, Ge M, Ji Q, et al. 2017 Chinese expert consensus on the clinical application of serum marker for thyroid cancer. Cancer Biology & Medicine, 2018, 15(4): 468-477. https://doi.org/10.20892/j.issn.2095-3941.2018.0084

656

Views

69

Downloads

3

Crossref

N/A

Web of Science

6

Scopus
Received: 26 April 2018
Accepted: 25 September 2018
Published: 01 November 2018
© 2018 by Cancer Biology & Medicine